Aushad Pharmacies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 09-11-2024
- Paid Up Capital ₹ 0.10 M
as on 09-11-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 09-11-2024
About Aushad Pharmacies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 Cr.
Chandragupta Jain and Harish Darera serve as directors at the Company.
- CIN/LLPIN
U24239KA2021PTC146393
- Company No.
146393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aushad Pharmacies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandragupta Jain  | Director | 12-Apr-2021 | Current |
| Harish Darera | Director | 12-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Aushad Pharmacies.
Aushad Pharmacies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aushad Pharmacies?
Unlock access to Aushad Pharmacies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aushad Distributors Private LimitedActive 17 years 8 monthsChandragupta Jain and Harish Darera are mutual person
Shiv Hari Pharmaceuticals Private LimitedActive 24 years 2 monthsChandragupta Jain and Harish Darera are mutual person
- Aushad Pharma Distributors Private LimitedActive 6 years 7 days
Chandragupta Jain and Harish Darera are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Sep 2021 | ₹5.00 Cr | Open |
How Many Employees Work at Aushad Pharmacies?
Aushad Pharmacies has a workforce of 45 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aushad Pharmacies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aushad Pharmacies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
